Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis

Haematologica. 2020 May;105(5):e210-e212. doi: 10.3324/haematol.2019.222471. Epub 2019 Sep 12.

Authors

Jingshi Wang¹, Yini Wang¹, Lin Wu¹, Xinkai Wang¹, Zhili Jin¹, Zhuo Gao¹, Zhao Wang²

Affiliations

¹ Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
² Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China zhaowww263@yahoo.com.

No abstract available

Publication types

Letter

MeSH terms

Humans
Lymphohistiocytosis, Hemophagocytic* / drug therapy
Nitriles
Pyrazoles / therapeutic use
Pyrimidines

Substances

Nitriles
Pyrazoles
Pyrimidines
ruxolitinib